SR9009 (Stenabolic): Mouse Studies & Status | Dose Track
App Library Tools Pricing Download
[Research compound · Compound guide]

SR9009 (Stenabolic): what it is, mouse studies and status

Amounts studied · Approval status · Half-life notes

What is SR9009?

SR9009 (sold as stenabolic) is a synthetic small molecule, first described in 2012, that switches on REV-ERB, proteins that help run the body clock and metabolism. It is not a peptide or a SARM. It has been studied only in cells and animals and is not approved for human use.

Also known as: Stenabolic, SR-9009.

Amounts studied

For SR9009, there is no approved product and no published human trial, so there are no label strengths or studied human amounts.

Approval status and how it is used

SR9009 is not approved, and we could not find any published study that gave it to people. WADA bans Rev-erb-alpha agonists, naming SR9009, banned in and out of competition under "metabolic modulators" (S4.4.1).

In the first paper (Solt 2012), REV-ERB agonists changed the daily rhythm of clock genes in mice, raised energy use, and in obese mice reduced fat mass and improved blood fats and blood sugar. A 2013 mouse study (Woldt) found that switching on Rev-erb-alpha increased exercise capacity. A 2019 study (Dierickx) found that SR9009 still changed cell survival, metabolism and gene activity in mouse cells that had no REV-ERB at all, so not all of its effects go through REV-ERB. Mouse results often do not carry over to people.

When researchers tested 44 products sold online as SARMs (Van Wagoner 2017), some contained SR9009.

SR9009 half-life and time to peak

  • Half-lifeNot listed
  • Time to peak (Tmax)Not listed

We could not find a published human half-life or time to peak, so we do not list one. Figures quoted online usually come from animal studies.

How to track SR9009 in Dose Track

  1. Add SR9009 as a custom compound. Start typing its name and Dose Track fills in the details from its research library for you to check, and it sits next to everything else you take.
  2. Log each dose when you take it so your history shows exactly what you took and when.
  3. Set reminders on your own schedule, whether that is daily, weekly or every few days.
  4. Your log is stored on your phone and no account is needed. Data only leaves it for features you choose, like AI answers and lab reading.

How Dose Track handles peptides · Reconstitution calculator · Half-life calculator

Cardarine (GW501516)GW501516, GW1516 SLU-PP-332 MOTS-c 5-Amino-1MQ5-amino-1-methylquinolinium, NNMT inhibitor

Frequently asked questions

What is the half-life of SR9009?+
We could not find a published human half-life or time to peak, so we do not list one. Figures quoted online usually come from animal studies.
Has SR9009 been tested in people?+
Not in any published study we could find. The research is in cells and mice (Solt 2012; Woldt 2013; Dierickx 2019).
Can I track SR9009 in Dose Track?+
Yes. SR9009 is in Dose Track's research library, so when you add it as a custom compound its details are filled in for you to check. You can then log each dose next to your other compounds, set reminders on your own schedule, and see your history next to your lab results. Your log is stored on your phone and no account is needed. Data only leaves it for features you choose, like AI answers and lab reading.

Sources

  1. Solt LA, et al. Regulation of circadian behaviour and metabolism by synthetic REV-ERB agonists. Nature. 2012;485(7396):62-68.
  2. Woldt E, et al. Rev-erb-α modulates skeletal muscle oxidative capacity by regulating mitochondrial biogenesis and autophagy. Nat Med. 2013;19(8):1039-1046.
  3. Dierickx P, et al. SR9009 has REV-ERB-independent effects on cell proliferation and metabolism. Proc Natl Acad Sci U S A. 2019;116(25):12147-12152.
  4. World Anti-Doping Agency. 2026 Prohibited List (S1.2 other anabolic agents; S2.2.1; S4.4.1 metabolic modulators; S6 stimulants).
  5. Van Wagoner RM, et al. Chemical composition and labeling of substances marketed as selective androgen receptor modulators and sold via the internet. JAMA. 2017;318(20):2004-2010.

All compound guides · Reconstitution calculator · Supported medications